Li Weihan, Dong Chong, Sun Chao, Wang Kai, Zheng Weiping, Wei Xinzhe, Han Chao, Yang Yang, Wang Zhen, Cui Ganlin, Li Linxiao, Gao Wei
The First Central Clinical School, Tianjin Medical University, Tianjin, China.
Department of Liver Transplantation, Organ Transplantation Center, Tianjin First Central Hospital, Tianjin, China.
Pediatr Transplant. 2025 Jun;29(4):e70089. doi: 10.1111/petr.70089.
A growing number of studies indicate that acute kidney injury (AKI) and the pattern of recovery after kidney injury are associated with poor outcomes for grafts and long-term renal function after liver transplantation (LT). However, few systematic studies have been conducted on the pediatric liver transplantation (PLT) population.
In this single-centered retrospective observational study, according to AKI degree and whether AKI was persistent, patients were divided into three groups: non-AKI/stage 1 AKI, stage 2/3 transient AKI, and stage 2/3 persistent AKI. We compared the survival of patients, graft, and chronic kidney disease (CKD) among the three groups, analyzing the risk factors for the stage 2/3 persistent AKI.
Among 700 patients, the total incidence of AKI was 39.57%; of children with stage 2/3 AKI, the condition was persistent in 38.06%. In the stage 2/3 persistent-AKI group, the risk of graft loss was 3.264× greater than in the no-AKI/stage 1 AKI group and 4.329× greater than in the stage 2/3 transient AKI group. Pediatric End-stage Liver Disease (PELD) score, preoperative estimated glomerular filtration rate (eGFR), duration of vena cava occlusion, postoperative respiratory support time, and postoperative early allograft dysfunction (EAD) were significantly correlated with the occurrence of stage 2/3 persistent AKI.
By combining AKI recovery mode with AKI grading, clinicians can screen out stage 2/3 persistent AKI with a worse prognosis. This method was more accurate in predicting prognosis than applying AKI grading alone.
越来越多的研究表明,急性肾损伤(AKI)及肾损伤后的恢复模式与肝移植(LT)后移植物的不良预后和长期肾功能相关。然而,针对小儿肝移植(PLT)人群的系统性研究较少。
在这项单中心回顾性观察研究中,根据AKI程度及AKI是否持续存在,将患者分为三组:非AKI/1期AKI、2/3期短暂性AKI和2/3期持续性AKI。我们比较了三组患者、移植物的生存率及慢性肾脏病(CKD)情况,分析了2/3期持续性AKI的危险因素。
700例患者中,AKI的总发生率为39.57%;在2/3期AKI患儿中,病情持续存在的占38.06%。在2/3期持续性AKI组中,移植物丢失风险比非AKI/1期AKI组高3.264倍,比2/3期短暂性AKI组高4.329倍。小儿终末期肝病(PELD)评分、术前估计肾小球滤过率(eGFR)、腔静脉阻断时间、术后呼吸支持时间及术后早期移植物功能障碍(EAD)与2/3期持续性AKI的发生显著相关。
通过将AKI恢复模式与AKI分级相结合,临床医生可筛选出预后较差的2/3期持续性AKI。该方法在预测预后方面比单独应用AKI分级更准确。